ZA978359B - Novel treatment - Google Patents

Novel treatment

Info

Publication number: ZA978359B
Authority: ZA; South Africa
Prior art keywords: novel treatment; novel; treatment
Prior art date: 1996-09-18

Application number

ZA978359A

Other languages

English (en)

Inventor

John Morris Evans

Andrew A Parsons

Mervyn Thompson

Neil Upton

Original Assignee

Smithkline Beecham Plc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-09-18

Filing date

1997-09-17

Publication date

1999-03-17

1997-09-17 Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc

1999-03-17 Publication of ZA978359B publication Critical patent/ZA978359B/xx

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Psychiatry (AREA)
Epidemiology (AREA)
Hospice & Palliative Care (AREA)
Psychology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Pyrane Compounds (AREA)

ZA978359A 1996-09-18 1997-09-17 Novel treatment ZA978359B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB9619492.3A GB9619492D0 (en)	1996-09-18	1996-09-18	Novel treatment

Publications (1)

Publication Number	Publication Date
ZA978359B true ZA978359B (en)	1999-03-17

Family

ID=10800127

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA978359A ZA978359B (en)	1996-09-18	1997-09-17	Novel treatment

Country Status (30)

Country	Link
EP (1)	EP0939630B1 (de)
JP (1)	JP2001500520A (de)
KR (1)	KR20000036184A (de)
CN (1)	CN1230885A (de)
AP (1)	AP9901473A0 (de)
AR (1)	AR008838A1 (de)
AT (1)	ATE270102T1 (de)
AU (1)	AU730465B2 (de)
BG (1)	BG103252A (de)
BR (1)	BR9712030A (de)
CA (1)	CA2266681A1 (de)
DE (1)	DE69729735T2 (de)
DZ (1)	DZ2311A1 (de)
EA (1)	EA199900306A1 (de)
ES (1)	ES2223075T3 (de)
GB (1)	GB9619492D0 (de)
HU (1)	HUP9904638A3 (de)
ID (2)	ID23175A (de)
IL (1)	IL128786A0 (de)
MA (1)	MA24321A1 (de)
NO (1)	NO991292L (de)
NZ (1)	NZ334271A (de)
OA (1)	OA10998A (de)
PE (1)	PE109898A1 (de)
PL (1)	PL332313A1 (de)
SK (1)	SK35199A3 (de)
TR (1)	TR199900527T2 (de)
UY (1)	UY24717A1 (de)
WO (1)	WO1998011890A1 (de)
ZA (1)	ZA978359B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7119214B2 (en) *	2004-04-13	2006-10-10	Cephalon France	Thio-substituted tricyclic and bicyclic aromatic methanesulfinyl derivatives
US20110319482A1 (en) *	2008-06-05	2011-12-29	Peter Blower	Novel treatments
EP2307004A1 (de) *	2008-06-05	2011-04-13	Minster Research Limited	Neue behandlungen
US8952034B2 (en)	2009-07-27	2015-02-10	Gilead Sciences, Inc.	Fused heterocyclic compounds as ion channel modulators
CA2782631A1 (en) *	2009-12-03	2011-06-09	Proximagen Ltd	Treatment of infectious diseases
US20130018091A1 (en) *	2009-12-03	2013-01-17	Peter Blower	Treatment of allodynia and hyperalgesia
BR112012033402A2 (pt)	2010-07-02	2017-01-24	Gilead Sciences Inc	moduladores de canais de íons conforme os compostos heterocíclicos fundidos
CA2834164A1 (en)	2011-05-10	2012-11-15	Gilead Sciences, Inc.	Fused benzoxazinones as ion channel modulators
TW201837023A (zh)	2011-07-01	2018-10-16	美商基利科學股份有限公司	作為離子通道調節劑之稠合雜環化合物
NO3175985T3 (de)	2011-07-01	2018-04-28
CN106397317B (zh) *	2016-09-26	2019-03-22	天津师范大学	1,2,3,4-四氢喹啉化合物及其合成方法与应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9112721D0 (en) *	1991-06-13	1991-07-31	Smithkline Beecham Plc	Novel treatment
US5510375A (en) *	1993-11-19	1996-04-23	Warner-Lambert Company	Coumarin derivatives as protease inhibitors and antiviral agents
HUT76136A (en) *	1994-06-10	1997-06-30	Smithkline Beecham Plc	Benzopyran compounds and their use as therapeutic agents
GB9411635D0 (en) *	1994-06-10	1994-08-03	Smithkline Beecham Plc	Novel treatment

1996
- 1996-09-18 GB GBGB9619492.3A patent/GB9619492D0/en active Pending
1997
- 1997-09-15 AP APAP/P/1999/001473A patent/AP9901473A0/en unknown
- 1997-09-15 ES ES97909300T patent/ES2223075T3/es not_active Expired - Lifetime
- 1997-09-15 AU AU47047/97A patent/AU730465B2/en not_active Ceased
- 1997-09-15 ID IDW990097A patent/ID23175A/id unknown
- 1997-09-15 WO PCT/EP1997/005168 patent/WO1998011890A1/en not_active Ceased
- 1997-09-15 KR KR1019997002238A patent/KR20000036184A/ko not_active Withdrawn
- 1997-09-15 CA CA002266681A patent/CA2266681A1/en not_active Abandoned
- 1997-09-15 PL PL97332313A patent/PL332313A1/xx unknown
- 1997-09-15 BR BR9712030A patent/BR9712030A/pt not_active IP Right Cessation
- 1997-09-15 NZ NZ334271A patent/NZ334271A/en unknown
- 1997-09-15 IL IL12878697A patent/IL128786A0/xx unknown
- 1997-09-15 AT AT97909300T patent/ATE270102T1/de not_active IP Right Cessation
- 1997-09-15 DE DE69729735T patent/DE69729735T2/de not_active Expired - Fee Related
- 1997-09-15 EA EA199900306A patent/EA199900306A1/ru unknown
- 1997-09-15 TR TR1999/00527T patent/TR199900527T2/xx unknown
- 1997-09-15 JP JP10514309A patent/JP2001500520A/ja not_active Ceased
- 1997-09-15 SK SK351-99A patent/SK35199A3/sk unknown
- 1997-09-15 CN CN97197979A patent/CN1230885A/zh active Pending
- 1997-09-15 HU HU9904638A patent/HUP9904638A3/hu unknown
- 1997-09-15 EP EP97909300A patent/EP0939630B1/de not_active Expired - Lifetime
- 1997-09-16 MA MA24799A patent/MA24321A1/fr unknown
- 1997-09-16 AR ARP970104238A patent/AR008838A1/es not_active Application Discontinuation
- 1997-09-16 UY UY24717A patent/UY24717A1/es not_active Application Discontinuation
- 1997-09-16 ID IDP973201A patent/ID19542A/id unknown
- 1997-09-17 DZ DZ970161A patent/DZ2311A1/xx active
- 1997-09-17 ZA ZA978359A patent/ZA978359B/xx unknown
- 1997-09-18 PE PE1997000831A patent/PE109898A1/es not_active Application Discontinuation
1999
- 1999-03-15 BG BG103252A patent/BG103252A/xx unknown
- 1999-03-17 NO NO991292A patent/NO991292L/no not_active Application Discontinuation
- 1999-03-18 OA OA9900060A patent/OA10998A/en unknown

Also Published As

Publication number	Publication date
UY24717A1 (es)	2001-08-27
DE69729735D1 (de)	2004-08-05
BR9712030A (pt)	1999-08-24
GB9619492D0 (en)	1996-10-30
CN1230885A (zh)	1999-10-06
HUP9904638A2 (hu)	2001-05-28
ATE270102T1 (de)	2004-07-15
OA10998A (en)	2003-03-04
PE109898A1 (es)	1999-03-21
AR008838A1 (es)	2000-02-23
IL128786A0 (en)	2000-01-31
NO991292D0 (no)	1999-03-17
AU4704797A (en)	1998-04-14
ES2223075T3 (es)	2005-02-16
PL332313A1 (en)	1999-08-30
ID23175A (id)	2000-03-23
DE69729735T2 (de)	2005-07-14
EA199900306A1 (ru)	1999-08-26
CA2266681A1 (en)	1998-03-26
HUP9904638A3 (en)	2001-08-28
EP0939630A1 (de)	1999-09-08
AP9901473A0 (en)	1999-03-31
JP2001500520A (ja)	2001-01-16
TR199900527T2 (xx)	1999-06-21
DZ2311A1 (fr)	2002-12-28
ID19542A (id)	1998-07-23
AU730465B2 (en)	2001-03-08
KR20000036184A (ko)	2000-06-26
WO1998011890A1 (en)	1998-03-26
NO991292L (no)	1999-03-17
EP0939630B1 (de)	2004-06-30
BG103252A (en)	1999-09-30
SK35199A3 (en)	2000-07-11
NZ334271A (en)	2001-03-30
MA24321A1 (fr)	1998-04-01

Publication	Publication Date	Title
GB9411080D0 (en)	1994-07-20	Treatment
GB9700899D0 (en)	1997-03-05	Novel treatment
GB9519033D0 (en)	1995-11-15	Treatment
GB9619492D0 (en)	1996-10-30	Novel treatment
GB9410512D0 (en)	1994-07-13	Novel treatment
ZA976593B (en)	1999-01-25	Novel treatment
GB9411635D0 (en)	1994-08-03	Novel treatment
GB9608657D0 (en)	1996-07-03	Novel treatment
GB2355006B (en)	2001-07-04	Materials treatment
GB9625795D0 (en)	1997-01-29	Novel treatment
GB9612752D0 (en)	1996-08-21	Novel treatment
GB9721692D0 (en)	1997-12-10	Novel treatment
GB9411632D0 (en)	1994-08-03	Novel treatment
GB9620085D0 (en)	1996-11-13	Cosmetic treatment
GB9721693D0 (en)	1997-12-10	Novel treatment
GB9616414D0 (en)	1996-09-25	Novel treatment
GB9604046D0 (en)	1996-04-24	Novel treatment
GB9614739D0 (en)	1996-09-04	Novel treatment
GB9619493D0 (en)	1996-10-30	Novel treatment
GB9616410D0 (en)	1996-09-25	Novel treatment
GB9619073D0 (en)	1996-10-23	Novel treatment
GB9614751D0 (en)	1996-09-04	Novel treatment
GB9616413D0 (en)	1996-09-25	Novel treatment
GB9614740D0 (en)	1996-09-04	Novel treatment
GB9616409D0 (en)	1996-09-25	Novel treatment